Overview

Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)

Status:
Recruiting

Trial end date:
2024-07-30

Target enrollment:

Participant gender:

Summary

A Phase 3 Multi-Center, Randomized, Double Masked, Vehicle Controlled Study to Assess the Safety and Efficacy of ST-100 (vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed with Dry Eye Disease (DED)

Phase:

Phase 3

Details

Lead Sponsor:

ORA, Inc.

Collaborator:

Stuart Therapeutics, Inc.